Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
Cetylpyridinium Chloride Mouthwash to Reduce Shedding of Infectious SARS-CoV-2: A Double-Blind Randomized Clinical Trial.
An anti-SARS-CoV-2 metabolite is reduced in diabetes.
Heterogeneous Infectivity and Pathogenesis of SARS-CoV-2 Variants Beta, Delta and Omicron in Transgenic K18-hACE2 and Wildtype Mice.
Unraveling the antiviral activity of plitidepsin by subcellular and morphological analysis.
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19.
Performance of SARS-CoV-2 Antigen-Detecting Rapid Diagnostic Tests for Omicron and Other Variants of Concern.
Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection.
Physicochemical characterization of the recombinant lectin scytovirin and microbicidal activity of the SD1 domain produced in rice against HIV-1.
High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients.
Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice.